成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Struktur
502626-06-4
CAS-Nr.
502626-06-4
Englisch Name:
N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel
Synonyma:
Paclitaxel EP Impurity Q;N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel;Paclitaxel Impurity 17（Paclitaxel EP Impurity Q）;Paclitaxel EP Impurity Q N-debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxe;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-do;Paclitaxel impurity 16/Paclitaxel EP Impurity Q/N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel/(αR,βS)-α-Hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate;Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
CBNumber:
CB13956464
Summenformel:
C46H55NO14
Molgewicht:
845.94
MOL-Datei:
502626-06-4.mol

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Eigenschaften

Schmelzpunkt:
161-167°C
Siedepunkt:
936.0±65.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
storage temp. 
-20°C Freezer
L?slichkeit
Chloroform (Slightly), Methanol (Slightly)
pka
11.92±0.20(Predicted)
Aggregatzustand
Solid
Farbe
Off-White

Sicherheit

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel is an impurity of Paclitaxel (P132500); an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi''s sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Paclitaxel - Impurity Q.

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 44)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14332 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11922 58
Moxin Chemicals 		+8617320513646
 mike@molcoo.com China 9447 58
Guangzhou PI PI Biotech Inc 020-81716320 +86-13602409664
 Sales@pipitech.com China 3633 55
BOC Sciences 1-631-485-4226; 16314854226
 info@bocsci.com United States 14055 65
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
 sales@chem-strong.com China 18070 56
Shanghai Yihe Biological Technology Co., Ltd. 17721395025
 2423903095@qq.com China 4066 58
Henan Alfachem Co.,Ltd. 0371-0371-55051623 18137891487
 2853979817@qq.com China 9908 58
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 +86-13028896684;
 sales@rrkchem.com China 57423 58
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
 1979313431@qq.com China 9020 58
  • Paclitaxel EP Impurity Q
  • Paclitaxel Impurity 17（Paclitaxel EP Impurity Q）
  • Paclitaxel impurity 16/Paclitaxel EP Impurity Q/N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel/(αR,βS)-α-Hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9
  • Paclitaxel EP Impurity Q N-debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxe
  • Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
  • N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel
  • (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate
  • (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-do
  • 502626-06-4
  • 243233-98-7
Copyright 2019 ? ChemicalBook. All rights reserved